The AML1-ETO AML - M2 Test is a specialized diagnostic procedure aimed at detecting the presence of the AML1-ETO fusion gene, which is commonly associated with Acute Myeloid Leukemia (AML), particularly the M2 subtype. This genetic anomaly results from a translocation between chromosomes 8 and 21, which plays a significant role in the pathogenesis of the disease. The test is crucial for the accurate diagnosis, prognosis, and determination of appropriate treatment strategies for patients suspected of having AML M2.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test employs sophisticated techniques to ensure precise and reliable results. The cost of the AML1-ETO AML - M2 Test is set at 1050 AED, reflecting the advanced technology and expertise required to conduct this complex analysis. By identifying the specific genetic alteration, this test enables healthcare providers to tailor treatment plans more effectively, potentially improving patient outcomes in those affected by this type of leukemia.
The BCL2 test is a specialized diagnostic procedure aimed at detecting the BCL2 gene rearrangements within cells. BCL2, short for B-cell lymphoma 2, is a gene implicated in various forms of cancer, most notably in lymphomas. Its protein product plays a crucial role in regulating cell death (apoptosis), and its overexpression can lead to an increased survival of cancer cells, contributing to the development and progression of the disease.
At DNA Labs UAE, this test is conducted with precision and care, leveraging advanced molecular techniques to provide accurate results. The test is crucial for patients suspected of having lymphomas or other related conditions, as it helps in confirming the diagnosis, guiding treatment decisions, and providing prognostic information. The cost of the BCL2 test at DNA Labs UAE is 1050 AED, reflecting the sophisticated nature of the testing and the invaluable insights it offers into the patient's health status. By identifying BCL2 gene rearrangements, healthcare providers can tailor treatment strategies more effectively, potentially improving patient outcomes.
The BCL6 test is a specialized diagnostic procedure designed to detect the presence and analyze the expression of the BCL6 gene. This gene plays a crucial role in the development and function of the immune system, and its abnormal expression is often associated with certain types of lymphoma, particularly diffuse large B-cell lymphoma (DLBCL). By assessing the BCL6 gene, healthcare professionals can gain valuable insights into the nature of lymphomas, aiding in accurate diagnosis and the formulation of effective treatment plans.
The test involves collecting a sample of tissue or blood from the patient, which is then analyzed in a laboratory setting to assess the BCL6 gene's status. This analysis can help determine the prognosis of lymphoma and guide therapeutic decisions, making it an essential tool in the management of patients with this type of cancer.
At DNA Labs UAE, the BCL6 test is available for 1050 AED. DNA Labs UAE is equipped with state-of-the-art facilities and employs cutting-edge technologies to ensure precise and reliable test results. The lab's team of expert professionals is committed to providing high-quality diagnostic services, ensuring that patients receive the most accurate information regarding their health condition.
The BCR-ABL CML AML ALL Test is a crucial diagnostic tool used in the detection of specific genetic abnormalities associated with various forms of leukemia, including Chronic Myeloid Leukemia (CML), Acute Myeloid Leukemia (AML), and Acute Lymphoblastic Leukemia (ALL). This test identifies the presence of the BCR-ABL fusion gene, a result of the translocation between chromosome 9 and chromosome 22, which is a hallmark of these blood cancers. The detection of this gene is vital for confirming the diagnosis, guiding treatment choices, and monitoring response to therapy.
DNA Labs UAE offers this specialized test for a cost of 1050 AED. Conducted in a state-of-the-art facility, the test ensures high accuracy and reliability. By opting for this test at DNA Labs UAE, patients and healthcare providers can expect results that will aid in the effective management and treatment of leukemia, leveraging advanced genetic testing technologies to provide crucial insights into the patient's specific condition.
The "Beta Thalassemia-9 Common Mutations Screening Single Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify the presence of the most prevalent mutations associated with Beta Thalassemia. This genetic disorder is characterized by reduced production of the beta-globin chain of hemoglobin, leading to varying degrees of anemia and other health complications. The test specifically targets nine common mutations, providing a focused approach to diagnosing this condition. Priced at 1050 AED, the test offers a cost-effective solution for individuals seeking a comprehensive analysis of their genetic predisposition to Beta Thalassemia. Conducted in the advanced facilities of DNA Labs UAE, this test is a crucial tool for early detection and management of the disorder, facilitating timely interventions and informed healthcare decisions.
The CCDN1 Test, offered at DNA Labs UAE, is a specialized diagnostic procedure aimed at analyzing specific genetic markers. With a test cost of 1050 AED, this assessment is crucial for individuals seeking in-depth insights into their genetic makeup for various health, ancestry, or personal reasons. DNA Labs UAE, known for its state-of-the-art facilities and expert team, ensures accurate and reliable results, making the CCDN1 Test a valuable tool for those looking to understand their genetic profile comprehensively.
The Chromosome 21 Test, offered by DNA Labs UAE, is a specialized diagnostic tool designed to detect abnormalities related to chromosome 21, which is most commonly associated with Down syndrome (Trisomy 21). This non-invasive test analyzes the genetic material to identify any extra copies of chromosome 21 that may be present, indicating the likelihood of Down syndrome. Additionally, it can provide insights into other chromosome 21 related disorders. Priced at 1050 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability. This test is crucial for expecting parents or individuals seeking genetic counseling, providing them with essential genetic information that can aid in early diagnosis and management of chromosome 21 associated conditions.
The C-Myc ALL NHL Test is a specialized diagnostic procedure aimed at detecting the presence of the C-Myc gene rearrangement, which is often associated with certain types of cancers, particularly Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin Lymphoma (NHL). This test plays a crucial role in the diagnosis, prognosis, and management of patients suffering from these malignancies. By identifying the C-Myc gene rearrangement, healthcare providers can tailor treatment plans more effectively, potentially improving patient outcomes.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, this test represents the cutting edge in cancer genetics testing. The lab is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results.
The cost of the C-Myc ALL NHL Test at DNA Labs UAE is 1050 AED. While the price may seem steep, the value of the information it provides for managing and treating ALL and NHL can be invaluable. Patients and healthcare providers considering this test should also explore insurance coverage options and any available financial assistance programs to help offset the cost.
The CRLF2 CML AML ALL Test is a specialized diagnostic assessment designed to detect genetic abnormalities associated with various forms of leukemia, including Chronic Myeloid Leukemia (CML), Acute Myeloid Leukemia (AML), and Acute Lymphoblastic Leukemia (ALL). This test specifically targets the CRLF2 gene to identify mutations or alterations that may contribute to the development or progression of these blood cancers. Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers a comprehensive approach to understanding the genetic underpinnings of leukemia. The cost of the test is set at 1050 AED, providing patients and healthcare providers with crucial information that can guide treatment decisions and improve patient outcomes.
The Cytomegalovirus (CMV) Quantitative PCR Test is a highly sensitive diagnostic procedure used to detect the presence and measure the amount of CMV DNA in a patient's body fluids, typically blood or urine. This test is crucial for identifying CMV infections, which can cause severe health issues, particularly in immunocompromised individuals such as organ transplant recipients, HIV/AIDS patients, and newborns. By quantifying the viral load, healthcare providers can assess the severity of the infection, monitor disease progression, and tailor treatment strategies effectively.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, the CMV Quantitative PCR Test utilizes the polymerase chain reaction (PCR) technique to amplify small segments of the CMV DNA, making it possible to detect even low levels of the virus with high accuracy. This advanced method ensures rapid and reliable results, critical for timely intervention.
The cost of the CMV Quantitative PCR Test at DNA Labs UAE is set at 1050 AED. This investment covers the state-of-the-art testing procedure and the expertise of the laboratory's medical professionals, providing patients with quality diagnostic services to support their healthcare needs.
